Hema 2 Lec - MIDTERM REVIEW QUESTIONS

5.0(1)
studied byStudied by 25 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/101

flashcard set

Earn XP

Description and Tags

Last updated 12:37 PM on 3/19/24
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai

No analytics yet

Send a link to your students to track their progress

102 Terms

1
New cards

Endothelial cell

CH. 35 REVIEW QUESTIONS:

What intimal cell synthesizes and stores von Willebrand factor (VWF)?

2
New cards

Tissue factor

CH. 35 REVIEW QUESTIONS:

What subendothelial structural protein triggers coagulation through activation of factor VII?

3
New cards

Fibrinogen

CH. 35 REVIEW QUESTIONS:

What coagulation plasma protein should be assayed when platelets fail to aggregate properly?

4
New cards

Carboxylates the factors to allow calcium binding

CH. 35 REVIEW QUESTIONS:

What is the primary role of vitamin K for the prothrombin group factors?

5
New cards

Thrombin proteolysis of fibrinogen

CH. 35 REVIEW QUESTIONS:

What is the source of prothrombin fragment F1.2?

6
New cards

Factor IXa, factor X

CH. 35 REVIEW QUESTIONS:

What serine protease forms a complex with factor VIIIa, and what is the substrate of this complex?

7
New cards

TPA

CH. 35 REVIEW QUESTIONS:

What protein secreted by endothelial cells activates fibrinolysis?

8
New cards

APC and protein S

CH. 35 REVIEW QUESTIONS:

What two regulatory proteins form a complex that digests activated factors V and VIII?

9
New cards

Mediate platelet adhesion and serve as a carrier molecule for factor VIII

CH. 35 REVIEW QUESTIONS:

What are the primary roles of VWF?

10
New cards

The liver

CH. 35 REVIEW QUESTIONS:

Most coagulation factors are synthesized in:

11
New cards

Lead to the formation of a stable fibrin clot

CH. 35 REVIEW QUESTIONS:

The events involved in secondary hemostasis:

12
New cards

Factor XIII

CH. 35 REVIEW QUESTIONS:

Which of the following coagulation factors is activated by thrombin and mediates the stabilization of the fibrin clot?

13
New cards

AT, TFPI

CH. 35 REVIEW QUESTIONS:

Which of the following endogenous plasma inhibitors is (are) important for the control of excessive thrombin generation?

14
New cards

Trauma-induced coagulopathy

CH. 36 REVIEW QUESTION

What is the most common acquired bleeding disorder?

15
New cards

Central nervous system bleed

CH. 36 REVIEW QUESTION

Which is a typical form of anatomic bleeding?

16
New cards

Factor VII deficiency, the PT

CH. 36 REVIEW QUESTION

What factor becomes deficient early in liver disease, and what assay does its deficiency prolong?

17
New cards

Hypofibrinogenemia

CH. 36 REVIEW QUESTION

Which of the following conditions causes a prolonged thrombin time?

18
New cards

Subtype 2B

CH. 36 REVIEW QUESTION

In what type or subtype of VWD is the RIPA test result positive when ristocetin is used at a concentration of less than 0.5 mg/mL?

19
New cards

Vitamin K and four-factor PCC

CH. 36 REVIEW QUESTION

What is the typical treatment for vitamin K deficiency when the patient is bleeding?

20
New cards

Factor XIII

CH. 36 REVIEW QUESTION

If a patient has anatomic soft tissue bleeding and poor wound healing, but the PT, PTT, TT, platelet count, and platelet functional assay results are normal, what factor deficiency is possible?

21
New cards

rFVIIa

CH. 36 REVIEW QUESTION

What therapy may be used for a hemophilic boy who is bleeding and who has a high FVIII inhibitor titer?

22
New cards

Type 1

CH. 36 REVIEW QUESTION

What is the most prevalent form of VWD?

23
New cards

Factor V assay

CH. 36 REVIEW QUESTION

Which of the following assays is used to distinguish vitamin K deficiency from liver disease?

24
New cards

Defects in primary hemostasis

CH. 36 REVIEW QUESTION

Mucocutaneous hemorrhage is typical of:

25
New cards

Bleeding into the joints (hemarthroses)

CH. 37 REVIEW QUESTION

The clinical presentation of platelet-related bleeding may include all of the following except:

26
New cards

Glanzmann thrombasthenia

CH. 37 REVIEW QUESTION

A defect in GP IIb/IIIa causes:

27
New cards

Abnormal platelet response to ristocetin

CH. 37 REVIEW QUESTION

Patients with Bernard-Soulier syndrome have which of the following laboratory test findings?

28
New cards

Storage pool defects

CH. 37 REVIEW QUESTION

Which of the following is the most common of the hereditary platelet function defects?

29
New cards

Altered expression of phospholipids on the platelet membrane

CH. 37 REVIEW QUESTION

A reduction in thrombin generation in patients with Scott syndrome results from:

30
New cards

Decreased numbers of a granules and dense granules

CH. 37 REVIEW QUESTION

The impaired platelet function in myeloproliferative neoplasms results from:

31
New cards

Impaired membrane activation, owing to protein coating

CH. 37 REVIEW QUESTION

The platelet defect associated with increased paraproteins is:

32
New cards

NO

CH. 37 REVIEW QUESTION

In uremia, platelet function is impaired by higher than normal levels of:

33
New cards

Anti-GP IIb/IIIa antibodies

CH. 37 REVIEW QUESTION

Thrombocytopenia associated with the use of cardiopulmonary bypass is not caused by:

34
New cards

Thromboxane A2

CH. 37 REVIEW QUESTION

Aspirin ingestion blocks the synthesis of:

35
New cards

Direct binding to GP IIb/IIIa

CH. 37 REVIEW QUESTION

A mechanism of antiplatelet drugs targeting GP IIb/IIIa function is:

36
New cards

Ehlers-Danlos syndrome

CH. 37 REVIEW QUESTION

Which is a congenital qualitative platelet disorder?

37
New cards

May-Hegglin anomaly

CH. 38 Review Question:

The Autosomal Dominant Disorder associated with decreased platelet production is

38
New cards

Large Overactive Platelets

CH. 38 Review Question:

Which of the following is not a hallmark of ITP?

39
New cards

HPA-1a

CH. 38 Review Question:

The specific antigen most commonly responsible for the development of NAIT is

40
New cards

Acute ITP

CH. 38 Review Question:

A 2-year-old child with an unexpected platelet count of 15,000/mL and a recent history of a viral infection most likely has?

41
New cards

Anagrelide

CH. 38 Review Question:

Which drug causes a reduction in platelet count by inhibiting megakaryocyte maturation?

42
New cards

Mucosal bleeding

CH. 38 Review Question:

A defect in primary hemostasis (platelet response to an injury) often results in?

43
New cards

The combination of the drug and the platelet membrane protein to which it is bound

CH. 38 Review Question:

When a drug acts as a hapten to induce thrombocytopenia, an antibody forms against which of the following?

44
New cards

Abnormal bone formation, including hypoplasia of the forearms

CH. 38 Review Question:

TAR refers to

45
New cards

The mother has an autoimmune antibody to her own platelets, which crosses the placenta and reacts with the infant’s platelets.

CH. 38 Review Question:

Neonatal autoimmune thrombocytopenia occurs when

46
New cards

Diarrhea caused by Shigella species

CH. 38 Review Question:

HUS in children is associated with

47
New cards

Atypical HUS

CH. 38 Review Question:

Treatment with an anticomplement agent such as eculizumab is first-line therapy for

48
New cards

Thrombocytosis is self-correcting

CH. 38 Review Question:

Which of the following statements regarding thrombocytosis is not true?

49
New cards

1 in 1000

CH. 39 REVIEW QUESTION:

What is the prevalence of venous thrombosis in the United States?

50
New cards

Predisposition to thrombosis secondary to a congenital or acquired disorder

CH. 39 REVIEW QUESTION:

What is thrombophilia?

51
New cards

Lupus anticoagulant

CH. 39 REVIEW QUESTION:

What acquired thrombosis risk factor is assessed in the hemostasis laboratory?

52
New cards

Adenocarcinoma

CH. 39 REVIEW QUESTION:

Trousseau syndrome, a low-grade chronic DIC, is often associated with what type of disorder?

53
New cards

APC resistance (factor V Leiden mutation)

CH. 39 REVIEW QUESTION:

What is the most common heritable thrombosis risk factor in Caucasians?

54
New cards

DRVVT

CH. 39 REVIEW QUESTION:

In most LAC profiles, what test is primary (performed first) because it detects LAC with the least interference?

  • It is considered the more specific of the LAC assays

55
New cards

Type I

CH. 39 REVIEW QUESTION:

A patient with venous thrombosis is tested for protein S deficiency. The protein S activity, antigen, and free antigen are all less than 65%, and the C4bBP level is normal. What type of deficiency is likely?

56
New cards

PAI-1

CH. 39 REVIEW QUESTION:

An elevated level of what fibrinolytic system assay is associated with arterial thrombotic risk?

57
New cards

It substitutes for plasminogen or TPA in the forming clot

CH. 39 REVIEW QUESTION:

How does lipoprotein (a) cause thrombosis?

58
New cards

DRVVT using high-phospholipid reagent

CH. 39 REVIEW QUESTION:

What test may be used to confirm the presence of LAC?

59
New cards

MTHFR 677

CH. 39 REVIEW QUESTION:

What molecular test may be used to confirm APC resistance?

60
New cards

Activated prothrombin complex concentrate

CH. 39 REVIEW QUESTION:

What therapeutic agent may occasionally cause DIC?

61
New cards

D-dimer

CH. 39 REVIEW QUESTION:

Which is not a fibrinolysis control protein?

62
New cards

Rule out deep venous thrombosis

CH. 39 REVIEW QUESTION:

What is the most important application of the quantitative D-dimer test?

63
New cards

Platelet count

CH. 39 REVIEW QUESTION:

What is the first laboratory assay necessary to detect heparin-induced thrombocytopenia?

64
New cards

2.5 to 3.5

CH. 40 REVIEW QUESTION:

What is the PT/INR therapeutic range for Coumadin therapy when a patient has a mechanical heart valve?

65
New cards

Acceptable for a patient with stable anticoagulation results after 6 months

CH. 40 REVIEW QUESTION:

Monitoring of a patient taking Coumadin showed that her anticoagulation results remained stable over a period of about 7 months. The frequency of her visits to the laboratory began to decrease, so the period between testing averaged 6 weeks. This new testing interval is:

66
New cards

It is convenient

CH. 40 REVIEW QUESTION:

What is the greatest advantage of point-of-care PT testing?

67
New cards

1 hour

CH. 40 REVIEW QUESTION:

You collect a citrated whole-blood specimen to monitor UFH therapy. What is the longest it may stand before the plasma must be separated from the cells?

68
New cards

ACT

CH. 40 REVIEW QUESTION:

What test is used to monitor high-dose UFH therapy during an interventional cardiology procedure?

69
New cards

PTT

CH. 40 REVIEW QUESTION:

What test is used most often to monitor UFH therapy in the central laboratory?

70
New cards

Chromogenic anti-factor Xa heparin assay

CH. 40 REVIEW QUESTION:

What test is used most often to monitor LMWH therapy in the central laboratory?

71
New cards

It has a predictable dose response

CH. 40 REVIEW QUESTION:

What is an advantage of LMWH therapy over UFH therapy?

72
New cards

HIT

CH. 40 REVIEW QUESTION:

In what situation is an intravenous DTI used?

73
New cards

ECT

CH. 40 REVIEW QUESTION:

What laboratory test may be used to monitor intravenous DTI therapy when PTT results are unreliable?

74
New cards

Platelet aggregometry

CH. 40 REVIEW QUESTION:

What is the reference method for detecting aspirin or clopidogrel resistance?

75
New cards

11-dehydrothromboxane B2

CH. 40 REVIEW QUESTION:

What is the name of the measurable platelet activation metabolite used in the AspirinWorks assay to monitor aspirin resistance?

76
New cards

Abciximab

CH. 40 REVIEW QUESTION:

Which is an intravenous antiplatelet drug used during an interventional cardiology procedure?

77
New cards

Rivaroxaban

CH. 40 REVIEW QUESTION:

Which of the following is a DOAC?

78
New cards

Clot-based test results are falsely prolonged

CH. 41 REVIEW QUESTION:

What happens if a coagulation specimen collection tube is underfilled?

79
New cards

First, or after a nonadditive tube

CH. 41 REVIEW QUESTION:

If you collect blood into a series of tubes, when in the sequence should the hemostasis (blue stopper) tube be filled?

80
New cards

In vitro platelet and coagulation activation

CH. 41 REVIEW QUESTION:

What is the effect of hemolysis on a hemostasis specimen?

81
New cards

10,000/uL

CH. 41 REVIEW QUESTION:

Except for platelet aggregometry, most coagulation testing must be performed on PPP, which is plasma with a platelet count less than:

82
New cards

0.32 mL

CH. 41 REVIEW QUESTION:

You wish to obtain a 5-mL specimen of whole-blood/ anticoagulant mixture. The patient’s hematocrit is 65%. What volume of anticoagulant should you use?

83
New cards

Glanzmann thrombasthenia

CH. 41 REVIEW QUESTION:

You perform whole-blood lumiaggregometry on a specimen from a patient who complains of easy bruising. Aggregation and secretion are diminished when the agonists thrombin, ADP, arachidonic acid, and collagen are used. What is the most likely platelet abnormality?

84
New cards

Serotonin release assay

CH. 41 REVIEW QUESTION:

What is the reference assay for HIT?

85
New cards

Ristocetin

CH. 41 REVIEW QUESTION:

What agonist is used in platelet aggregometry to detect VWD?

86
New cards

Prothrombin

CH. 41 REVIEW QUESTION:

Deficiency of which congenital single factor is likely when the PT result is prolonged and the PTT result is normal?

87
New cards

Vitamin K deficiency

CH. 41 REVIEW QUESTION:

A prolonged PT, a low factor VII level, but a normal factor V level are characteristic of an acquired coagulopathy associated with which of the following?

88
New cards

Lupus anticoagulant

CH. 41 REVIEW QUESTION:

The patient has deep vein thrombosis. The PTT is prolonged and is not corrected in an immediate mix of patient PPP with an equal part of PNP. What is the presumed condition?

89
New cards

DIC

CH. 41 REVIEW QUESTION:

What condition causes the most pronounced elevation in the result of the quantitative D-dimer assay?

90
New cards

Chromogenic substrate assay

CH. 41 REVIEW QUESTION:

What is the name given to the type of assay that uses a synthetic polypeptide substrate that releases a chromophore on digestion by its serine protease?

91
New cards

a2-antiplasmin

CH. 41 REVIEW QUESTION:

What component of the fibrinolytic process binds and neutralizes free plasmin?

92
New cards

Whole-genome sequencing

CH. 41 REVIEW QUESTION:

What type of high-throughput genomic sequencing is likely to become a standard clinical assay?

93
New cards

All of the above

CH. 42 REVIEW QUESTION:

Which of the following includes the advances made in technology in the coagulation lab?

94
New cards

It is not affected by lipemia in the test specimen

CH. 42 REVIEW QUESTION:

Which of the following is considered to be an advantage of the mechanical end-point detection methodology?

95
New cards

Viscoelastic

CH. 42 REVIEW QUESTION:

What method of detection is used in both the TEG and ROTEM?

96
New cards

Reagents and specimens usually are added manually by the operator

CH. 42 REVIEW QUESTION:

Which of the following is a feature of semiautomated coagulation testing analyzers?

97
New cards

Photo-optical clot detection

CH. 42 REVIEW QUESTION:

When a specimen has been flagged as being icteric by an automated coagulation analyzer, which method would be most susceptible to erroneous results because of the interfering substance?

98
New cards

Flow cytometry

CH. 42 REVIEW QUESTION:

Which of the following newer techniques can be used for the measurement of platelet function testing in patients with thrombocytopenia and in pediatrics?

99
New cards

Location of the manufacturer’s home office

CH. 42 REVIEW QUESTION:

All of the following are performance characteristics to consider in the selection of a coagulation analyzer except:

100
New cards

Detecting the time it takes for a clot to form as blood flows through a small aperture in a tube coated with platelet activators

CH. 42 REVIEW QUESTION:

Platelet function is measured by the PFA-100 using which of the following methods?